104 related articles for article (PubMed ID: 2988230)
1. Immunologic characterization of herpes simplex virus type 2 antigens ICP10 and ICSP11/12.
Flanders RT; Kucera LS; Raben M; Ricardo MJ
Virus Res; 1985 Apr; 2(3):245-60. PubMed ID: 2988230
[TBL] [Abstract][Full Text] [Related]
2. Immunological characterization of herpes simplex virus type 1 and 2 polypeptide(s) involved in viral ribonucleotide reductase activity.
Bacchetti S; Evelegh MJ; Muirhead B; Sartori CS; Huszar D
J Virol; 1984 Feb; 49(2):591-3. PubMed ID: 6319760
[TBL] [Abstract][Full Text] [Related]
3. The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) blocks apoptosis in hippocampal neurons, involving activation of the MEK/MAPK survival pathway.
Perkins D; Pereira EF; Gober M; Yarowsky PJ; Aurelian L
J Virol; 2002 Feb; 76(3):1435-49. PubMed ID: 11773417
[TBL] [Abstract][Full Text] [Related]
4. Vaccine potential of a herpes simplex virus type 2 mutant deleted in the PK domain of the large subunit of ribonucleotide reductase (ICP10).
Aurelian L; Kokuba H; Smith CC
Vaccine; 1999 Apr; 17(15-16):1951-63. PubMed ID: 10217594
[TBL] [Abstract][Full Text] [Related]
5. The novel protein kinase of the RR1 subunit of herpes simplex virus has autophosphorylation and transphosphorylation activity that differs in its ATP requirements for HSV-1 and HSV-2.
Peng T; Hunter JR; Nelson JW
Virology; 1996 Feb; 216(1):184-96. PubMed ID: 8614985
[TBL] [Abstract][Full Text] [Related]
6. The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) functions as a dominant regulator of apoptosis in hippocampal neurons involving activation of the ERK survival pathway and upregulation of the antiapoptotic protein Bag-1.
Perkins D; Pereira EF; Aurelian L
J Virol; 2003 Jan; 77(2):1292-305. PubMed ID: 12502846
[TBL] [Abstract][Full Text] [Related]
7. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
8. Expression of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is required for virus growth and neoplastic transformation.
Smith CC; Kulka M; Wymer JP; Chung TD; Aurelian L
J Gen Virol; 1992 Jun; 73 ( Pt 6)():1417-28. PubMed ID: 1318943
[TBL] [Abstract][Full Text] [Related]
9. Ras-GAP binding and phosphorylation by herpes simplex virus type 2 RR1 PK (ICP10) and activation of the Ras/MEK/MAPK mitogenic pathway are required for timely onset of virus growth.
Smith CC; Nelson J; Aurelian L; Gober M; Goswami BB
J Virol; 2000 Nov; 74(22):10417-29. PubMed ID: 11044086
[TBL] [Abstract][Full Text] [Related]
10. The PK domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) is required for immediate-early gene expression and virus growth.
Smith CC; Peng T; Kulka M; Aurelian L
J Virol; 1998 Nov; 72(11):9131-41. PubMed ID: 9765459
[TBL] [Abstract][Full Text] [Related]
11. The transmembrane helical segment but not the invariant lysine is required for the kinase activity of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10).
Luo JH; Aurelian L
J Biol Chem; 1992 May; 267(14):9645-53. PubMed ID: 1315764
[TBL] [Abstract][Full Text] [Related]
12. Study of ribonucleotide reductase in cells infected with six clinical isolates of herpes simplex virus type 2 (HSV-2) with mutations in its larger subunit.
Bapat AR; Grill SP; Nutter LM; Cheng YC
Virology; 1987 Nov; 161(1):249-51. PubMed ID: 2823465
[TBL] [Abstract][Full Text] [Related]
13. Identification of immediate-early-type cis-response elements in the promoter for the ribonucleotide reductase large subunit from herpes simplex virus type 2.
Wymer JP; Chung TD; Chang YN; Hayward GS; Aurelian L
J Virol; 1989 Jun; 63(6):2773-84. PubMed ID: 2542589
[TBL] [Abstract][Full Text] [Related]
14. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K
Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583
[TBL] [Abstract][Full Text] [Related]
15. A truncated protein kinase domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) expressed in Escherichia coli.
Luo JH; Smith CC; Kulka M; Aurelian L
J Biol Chem; 1991 Nov; 266(31):20976-83. PubMed ID: 1657940
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase activity associated with the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10).
Chung TD; Wymer JP; Smith CC; Kulka M; Aurelian L
J Virol; 1989 Aug; 63(8):3389-98. PubMed ID: 2545912
[TBL] [Abstract][Full Text] [Related]
17. Myristylation and polylysine-mediated activation of the protein kinase domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10).
Chung TD; Wymer JP; Kulka M; Smith CC; Aurelian L
Virology; 1990 Nov; 179(1):168-78. PubMed ID: 2171204
[TBL] [Abstract][Full Text] [Related]
18. A monoclonal antibody against HSV type 1 ribonucleotide reductase cross-reacts with the P0 protein of peripheral nerve myelin.
Höjeberg B; Ingemarsson R; Kristensson K; Lycke E; Olsson T
J Neurol Sci; 1991 Nov; 106(1):91-5. PubMed ID: 1723423
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glycosylation of herpes simplex virus glycoproteins: identification of antigenic and immunogenic partially glycosylated glycopeptides on the cell surface membrane.
Glorioso J; Szczesiul MS; Marlin SD; Levine M
Virology; 1983 Apr; 126(1):1-18. PubMed ID: 6189286
[TBL] [Abstract][Full Text] [Related]
20. AP-1 cis-response elements are involved in basal expression and Vmw110 transactivation of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10).
Zhu J; Aurelian L
Virology; 1997 May; 231(2):301-12. PubMed ID: 9168892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
